Literature DB >> 26888738

Association of XPF Levels and Genetic Polymorphism with Susceptibility to Ischemic Stroke.

Ying Ma1, Xiao-Dong Deng2, Yu Feng3, Wei Zhang2, Sun-Xian Wang1, Yun Liu4, Hong Liu5.   

Abstract

The xeroderma pigmentosum group F (XPF) gene participates in the pathophysiological process of ischemic stroke, and XPF polymorphisms might be associated with ischemic stroke susceptibility. This study aimed to investigate XPF messenger RNA (mRNA) levels in peripheral blood mononuclear cells and protein levels in plasma and to analyze the 30028T/C polymorphism (rs1799801) in ischemic stroke patients and controls. Levels of both mRNA and protein in ischemic stroke patients were significantly lower than in controls (P < 0.05). The C allele of the 30028T/C polymorphism significantly increased the risk of ischemic stroke (OR = 1.512, 95 % CI = 1.219-1.875). The CT and CC/CT genotypes of 30028T/C were observed significantly more frequently in ischemic stroke patients than in controls (CT: OR = 1.916, 95 % CI = 1.446-2.539; CC/CT: OR = 1.877, 95 % CI = 1.427-2.468). Similar results were obtained after adjusting for age, gender, and smoking status. Additionally, XPF plasma protein levels were significantly decreased in the CC/CT genotype compared with the TT genotype (P = 0.025). These data indicate that XPF might play an important role in the pathophysiological process of ischemic stroke, and the 30028T/C polymorphism might be associated with ischemic stroke susceptibility in a Chinese Han population.

Entities:  

Keywords:  Genetic susceptibility; Ischemic stroke; Single-nucleotide polymorphisms; Xeroderma pigmentosum group F (XPF)

Mesh:

Substances:

Year:  2016        PMID: 26888738     DOI: 10.1007/s12031-016-0729-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  48 in total

1.  Action of DNA repair endonuclease ERCC1/XPF in living cells.

Authors:  A B Houtsmuller; S Rademakers; A L Nigg; D Hoogstraten; J H Hoeijmakers; W Vermeulen
Journal:  Science       Date:  1999-05-07       Impact factor: 47.728

2.  Efficient discovery of single-nucleotide polymorphisms in coding regions of human genes.

Authors:  G Hu; B Modrek; H M F Riise Stensland; J Saarela; P Pajukanta; V Kustanovich; L Peltonen; S F Nelson; C Lee
Journal:  Pharmacogenomics J       Date:  2002       Impact factor: 3.550

3.  Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population.

Authors:  R Krupa; J Kasznicki; M Gajęcka; M Rydzanicz; K Kiwerska; D Kaczmarczyk; J Olszewski; K Szyfter; J Blasiak; A Morawiec-Sztandera
Journal:  Exp Oncol       Date:  2011-03

Review 4.  Molecular mechanisms of mammalian global genome nucleotide excision repair.

Authors:  Ludovic C J Gillet; Orlando D Schärer
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

5.  XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  Alec Vaezi; Xiaozhe Wang; Shama Buch; William Gooding; Lin Wang; Raja R Seethala; David T Weaver; Alan D D'Andrea; Athanassios Argiris; Marjorie Romkes; Laura J Niedernhofer; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2011-07-07       Impact factor: 12.531

6.  Association of CD40--1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population.

Authors:  Bikui Zhang; Tian Wu; Cuizhu Song; Min Chen; Huande Li; Ren Guo
Journal:  Int Immunopharmacol       Date:  2013-05-10       Impact factor: 4.932

7.  DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer.

Authors:  Brian M Alexander; Kam Sprott; D Allan Farrow; XiaoZhe Wang; Alan D D'Andrea; Stuart J Schnitt; Laura C Collins; David T Weaver; Judy E Garber
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

8.  Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.

Authors:  Jubao Duan; Mark S Wainwright; Josep M Comeron; Naruya Saitou; Alan R Sanders; Joel Gelernter; Pablo V Gejman
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Effect of Xeroderma pigmentosum complementation group F polymorphisms and H.pylori infection on the risk of gastric cancer.

Authors:  Li-Li Zhang; Fang Yang; Ting-Min Chang; Shu-Ping Dong; Ying-Ying Fan; Ting Lu
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

View more
  2 in total

1.  Correlation of xeroderma pigmentosum complementation group F expression with gastric cancer and prognosis.

Authors:  Peilin Li; Yuanzhong Ma
Journal:  Oncol Lett       Date:  2018-09-28       Impact factor: 2.967

2.  Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence.

Authors:  Huan Liu; Wei Zhang; Xiao-Dong Deng; Ying Ma; Yun Liu
Journal:  Mol Genet Genomic Med       Date:  2021-09-01       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.